Fasting hypertriglyceridemia in non insulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities

Journal of Clinical Endocrinology and Metabolism

Volumn 72, Issue 4, 1991, Pages 934-944

  Lewis, G F ^a   O'meara N M ^a   Soltys, P A ^a   Blackman, J D ^a   Iverius, P H ^a,b   Pugh, W L ^a   Getz, G S ^a   Polonsky, K S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; EATING; FASTING; FATTY ACIDS, NONESTERIFIED; FORECASTING; HEPARIN; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN; LIPASE; LIPIDS; LIPOPROTEINS; PANCREATIC HORMONES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; VITAMIN A;

EID: 0025857172     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-72-4-934     Document Type: Article

References (61)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974;23:105-11.
2. Ganda OP. Pathogenesis of macrovascular disease in the human diabetic [Review]. Diabetes. 1980;29:931-42.
3. Bierman EL, Brunzell JD. Interrelation of atherosclerosis, abnormal lipid metabolism and diabetes mellitus. In: Ktzen HM, Mahler RI, eds. Advances in modern nutrition. New York: Wiley and Sons; 1978;7:187-210.
4. Howard BV, Knowler WC, Vasquez B, Kennedy AL, Pettitt DJ, Bennet PH. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics. Arteriosclerosis. 1984;4:462-71.
5. Barrett-Connor E, Grundy SM, Holdbrook MJ. Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol. 1982;115:657-63.
6. Barrett-Connor E, Witztum JL, Holdbrook M. A community study of high density lipoproteins in adult non-insulin-dependent diabetics. Am J Epidemiol. 1983;117:186-92.
7. Santen RJ, Willis PW, Fajans SS. Atherosclerosis in diabetes mellitus. Arch Intern Med. 1972;130:833-43.
8. Kudo H. Serum triglyceride levels of untreated diabetics in relation to vascular lesions and obesity. Tohoku J Exp Med. 1969;97:47-56.
9. West KM, Ahuja MMS, Bennet PH, et al. The role of circulating glucose and triglyceride concentrations and their interaction with other risk factors as determinants of arterial disease in nine diabetic population samples from the WHO Multicenter Study. Diabetes Care. 1983;6:361-9.
10. Fontbonne AE, Eschwege F, Cambien J-L, et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia. 1989;32:300-4.
11. Weintraub MS, Eisenberg S, Breslow JL. Different patterns of postprandial lipoprotein metabolism in normal, type Ha, type III and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. J Clin Invest. 1987;79:1110-19.
12. Olson JA. Metabolism and function of vitamin A. Fed Proc. 1969;28:1670-7.
13. Goodman DS, Blomstrand R, Wenner B, Huang HS, Shiratori T. The intestinal absorption and metabolism of vitamin A and beta carotene in man. J Clin Invest. 1966;45:1615-23.
14. Ross AC, Zilversmit DB. Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoprotein in plasma of cholesterol fed rabbits. J Lipid Res. 1977;18:169-81.
15. Goodman DS, Huang HS, Shiratori T. Tissue distribution and metabolism of newly absorbed vitamin A in the rat. J Lipid Res. 1965;6:390-6.
16. Thompson KH, Hughes LB, Zilversmit DB. Lack of secretion of retinyl ester by livers of normal and cholesterol-fed rabbits. J Nutr. 1983;113:1995-2001.
17. Lenich CM, Ross AC. Chylomicron remnant-vitamin A metabolism by the human hepatoma cell line Hep G2. J Lipid Res. 1987;28:183-94.
18. Berr F, Kern Jr F. Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects. J Lipid Res. 1984;25:805-12.
19. Grundy SM, Mok HYI. Chylomicron clearance in normal and hyperlipidémie man. Metabolism. 1976;25:1225-39.
20. Prevalence Study Lipid Metabolism Branch, Division of Heart and Vascular Diseases, NHLBI, NIH, DHHS, USPHS. The Lipid Research Clinics Population Studies data book. NIH publication no. 80-1527. Washington DC: U.S. Government Printing Office; 1980;1.
21. American Diabetes Association. Position statement: nutritional recommendations and principles for individuals with diabetes mellitus. Diabetes Care 1987;10:126-32.
22. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 1959;234:466-8.
23. Mikac-Devic D, Stankovic H, Boskovic K. A method for determination of free fatty acids in serum. Clin Chim Acta. 1973;45:55-9.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
25. DeRuyter MGM, De Leenheer AP. Simultaneous determination of retinol and retinyl esters in serum or plasma by reversed-phase high-performance liquid chromatography. Clin Chem. 1978;24:1920-3.
26. Morgan CR, Lazarow A. Immunoassay of insulin: two antibody system. Plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes. 1963;12:115-26.
27. Faber OK, Binder C, Markussen J, et al. Characterizations of seven C-peptide antisera. Diabetes. 1978;27(Suppl 1):170-7.
28. Bouthillier D, Sing DF, Davignon J. Apolipoprotein phenotyping with a single gel method: application to the study of informative mating. J Lipid Res. 1983;24:1060-9.
29. Albers J, Whal P, Cabana V, Hazzard W, Hoover J. Quantitation of apolipoprotein A-l of human plasma high density lipoproteins. Metabolism. 1976;25:633-44.
30. Iverius PH, Ostlund-Lindqvist A. Preparation, characterization and measurement of lipoprotein lipase. Methods Enzymol. 1986;129(Part B):691-704.
31. Lewis GF, O’Meara NM, Soltys PA, et al. Postprandial lipoprotein metabolism in normal and obese subjects. Comparison after the vitamin A fat loading test. J Clin Endocrinol Metab. 1990;71:1041-50.
32. Nestel PJ. Relationship between plasma triglycerides and removal of chylomicrons. J Clin Invest. 1964;43:943-9.
33. Barr SI, Kottke BA, Mao SJT. Postprandial distribution of apoli-poproteins C-II and C-III in normal subjects and patients with mild hypertriglyceridemia: comparison of meals containing corn oil and medium-chain triglyceride oil. Metabolism. 1985;34:983-92.
34. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res. 1988;29:469-79.
35. Taskinen MR, Beltz WF, Harper I, et al. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism: studies before and after sulphonylurea therapy. Diabetes. 1986;35:1268-77.
36. Dunn FL, Raskin P, Bilheimer DW, Grundy SM. The effect of diabetic control on very low-density lipoprotein triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia. Metabolism. 1984;33:117-23.
37. Ginsberg H, Grundy SM. Very low density lipoprotein metabolism in non-ketotic diabetes mellitus: effect of dietary restriction. Diabetologia. 1982;23:421-5.
38. Howard BV, Reitman JS, Vasquez B, Zech L. Very-low-density lipoprotein triglyceride metabolism in non-insulin-dependent diabetes mellitus. Relationship to plasma insulin and free fatty acids. Diabetes. 1983;32:271-6.
39. Laakso M, Voutilainen E, Sarlund H, Aro A, Pyorala K, Penttila I. Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics. Atherosclerosis. 1985;56:271-81.
40. Abbot WGH, Lillioja S, Young AA, et al. Relationship between plasma lipoprotein concentration and insulin action in obese hy-perinsulinemic population. Diabetes. 1987;36:897-904.
41. Tobey TA, Greenfield M, Kraemer F, Reaven GM. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotrig-lyceridemic man. Metabolism. 1981;30:165-71.
42. Taylor KG, Galton DJ, Holdsworth G. Insulin-independent diabetes: a defect in the activity of lipoprotein lipase in adipose tissue. Diabetologia. 1979;16:313-7.
43. Brunzell JD, Hazzard WR, Porte Jr D, Bierman EL. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 1973;52:1578-85.
44. Abrams JJ, Ginsberg H, Grundy SM. Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes. 1982;31:903-10.
45. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473-85.
46. Floren C-H, Albers JJ, Bierman EL. Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells. Biochim Biophys Acta. 1981;663:336-49.
47. Simons LA, Dwyer T, Simons J, et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis. 1987;65:181-9.
48. Krauss XH, Groot P, van Ramshorst E, van Stipthout A, Chin-On S, van Tol A. Chylomicron metabolism in coronary atherosclerosis [Abstract]. Arteriosclerosis. 1987;7:531a-2a.
49. Brown MS, Goldstein JL, Fredrickson DS. Familial type 3 hyperlipoproteinemia (dysbetalipoproteinemia). In: Stanberry JB, Wyn-gaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease, 5th ed. New York: McGraw- Hill; 1983;655.
50. Tatami R, Mabuchi H, Ueda K, et al. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angio-graphically determined coronary artery disease. Circulation. 1981;64:1174-84.
51. Reardon MF, Nestel PJ, Craig IH, Harper RW. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 1985;71:881-8.
52. Krauss RM, Williams PT, Brensike J, et al. Intermediate-density lipoproteins and progression of coronary artery disease in hyper-cholesterolaemic men. Lancet. 1987;11:62-5.
53. Reaven GM. Non-insulin dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis [Review]. Metabolism. 1987;36(Suppl 1):1-8.
54. Havel RJ, Kane JP, Kashyap ML. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest. 1973;52:32-8.
55. Miller GJ, Miller NE. Plasma high density lipoproteins and development of ischaemic heart disease. Lancet. 1975;1:16-9.
56. Patsch JR, Prasad S, Gotto Jr AM, Bengtsson-Olivecrona G. Postprandial lipemia. A key for the conversion of high density lipoprotein 2 into high density lipoprotein 3 by hepatic lipase. J Clin Invest. 1984;74:2017-23.
57. Anderson DW, Nichols AV, Pan SS, Lindgren FT. High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. Atherosclerosis. 1978;29:161-79.
58. Harno K, Nikkila EA, Kuusi T. Plasma HDL-cholesterol and postheparin plasma hepatic endothelial lipase (HL) activity: relationship to obesity and non-insulin dependent diabetes (NIDDM) [Abstract]. Diabetologia. 1980;19:281.
59. Nikkila EA, Huttunen JK, Ehnholm C. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes. 1977;26:11-21.
60. Busby J, Coon P, Katzel L, et al. An upper body distribution of fat, abnormal postheparin lipases and reduced high density lipoproteins in obese sedentary men [Abstract]. Clin Res. 1989;37:249A.
61. Groot PH, Scheek LM, Jansen H. Liver lipase and high density lipoprotein. Lipoprotein changes after incubation of human serum with rat liver lipase. Biochim Biophys Acta. 1983;751:393-400